๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Edwards Lifesciences Corporation (EW)
NYSE: EW ยท Real-Time Price ยท USD
101.85
-2.03 (-1.95%)
At close: Nov 20, 2026, 4:00 PM EST
101.94
+0.09 (0.09%)
After-hours: Nov 20, 2026, 7:59 PM EST

Edwards Lifesciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6,6756,0685,4405,0104,4645,233
Revenue Growth
13.44%11.55%8.57%12.23%-14.69%19.29%
Gross Profit
5,2084,7334,3224,0323,7423,984
Operating Income
1,9241,6381,4811,4871,5421,587
Net Income
1,0211,0744,1751,4021,5221,503
Earnings Per Share
1.761.836.972.302.442.38
EPS Growth
-24.39%-73.70%202.39%-5.44%2.40%83.08%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Transcatheter Aortic Valve Replacement
4,8584,4884,1063,8803,5183,423
Transcatheter Mitral and Tricuspid Therapies
738.9550.6352.1197.6116.186
Surgical Structural Heart
1,0781,029981.3932.6829.7889.1
Revenue (Total)
6,6756,0685,4405,0104,4645,233

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,6934,2333,9811,6331,2151,467
Total Debt
704.5705.4700685.1691.3690.3
Net Cash (Debt)
3,9883,5283,281947.7524776.5
Net Cash Growth
26.70%7.51%246.25%80.86%-32.52%9.72%
Net Cash Per Share
6.886.025.481.560.841.23

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7171,595542.3895.81,2181,732
Capital Expenditures
-292.8-260.2-252.4-253-244.6-325.8
Free Cash Flow
1,4241,335289.9642.8973.61,406
Free Cash Flow Growth
77.08%360.50%-54.90%-33.98%-30.77%117.26%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
78.02%78.01%79.46%80.47%83.82%76.13%
Operating Margin
28.82%26.99%27.22%29.69%34.54%30.32%
Pretax Margin
21.46%20.98%28.46%27.39%34.04%32.53%
Profit Margin
15.30%17.69%76.75%27.99%34.09%28.73%
FCF Margin
21.34%22.00%5.33%12.83%21.81%26.88%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
57.8246.0810.4632.9830.3153.81
Forward PE
31.3430.9331.1928.4130.3552.98
P/FCF Ratio
41.1237.06150.6171.9447.3857.51
PS Ratio
8.778.158.039.2310.3315.46